Pharmanovia (Atnash Pharma) has announced the appointment of Carlos Diaz-Mor as Country Manager of Iberia, a newly created position with which the English multinational reinforces its commitment to Spain and Portugal.
Carlos Diaz-Mor has extensive experience in the pharmaceutical industry and in launching companies. It has recently joined Pharmanovia with the aim of directing strategies and boosting its success and growth in Spain and Portugal. It will also contribute to the development of Pharmanovia Iberia’s identity as an innovative company, whose portfolio consists of iconic brands from the pharmaceutical market, such as Naprosyn, Bonviva, Rocaltrol, Valium, etc.
According to C. Diaz-Mor, "every day I learn new things about the drug market, and the possibility of developing iconic brands in the markets of Spain and Portugal, I am passionate".
Carlos Diaz-Mor studied Pharmacy at the Complutense University of Madrid and has taken different courses in Negotiation, Marketing and Finance at both the Instituto de Empresa and the CEU Business School.
Diaz-Mor has gone through different positions, both national and international in laboratories, forming part of the Board in the launch of Teva Spain as Director of Marketing and Sales, launching new business units, in Genzyme, as Biosurgery Business Unit Manager. Working as Commercial Director in Effik, as well as moving to Hispano America and collaborating with the Mexican company Medix in its establishment in Colombia, as well as its development as an independent consultant, collaborating with various laboratories, both in the field of Gynecology, Cosmetics (BSB) or helping in the development of strategies of Commercial Excellent.
Quer ter sua movimentação publicada? Envie seu POST sobre sua nova posição de carreira para nossa sessão Onboard para o email dikajob@dikajob.com.br ou publique você mesmo, clicando aqui.
*Conteúdo exclusivo do DikaJob. Ao reproduzir, colocar a fonte e o link para o texto original.
